Malpica Castillo, Luis E <br/><br/>
Incidence and time course of neutropenia in patients treated with rituximab-based therapy for non-malignant immune-mediated hematologic diseases.  [electronic resource] 

 -  American journal of hematology  05 2020 
 - E117-E120 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.25751  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Immunological--adverse effects<br/>Female<br/>Hematologic Diseases<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Retrospective Studies<br/>Rituximab--adverse effects